Henry Pan

760 total citations
18 papers, 645 citations indexed

About

Henry Pan is a scholar working on Surgery, Biotechnology and Immunology. According to data from OpenAlex, Henry Pan has authored 18 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Biotechnology and 4 papers in Immunology. Recurrent topics in Henry Pan's work include Lipoproteins and Cardiovascular Health (6 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Ovarian function and disorders (2 papers). Henry Pan is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Ovarian function and disorders (2 papers). Henry Pan collaborates with scholars based in United States, Germany and Malaysia. Henry Pan's co-authors include Arthur R. DeVault, Eugene Ivashkiv, A. Arthur Sugerman, Brian N. Swanson, David Wang‐Iverson, Joseph Triscari, Raj K. Puri, Margot J. Mellies, Anthony L. Asher and Jeffrey N. Bruce and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and The American Journal of Gastroenterology.

In The Last Decade

Henry Pan

17 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henry Pan United States	10	287	128	111	111	99	18	645
Chiara Ricci Italy	11	427 1.5×	187 1.5×	96 0.9×	180 1.6×	16 0.2×	18	751
Ilaria Giunzioni United States	11	520 1.8×	147 1.1×	32 0.3×	256 2.3×	19 0.2×	13	733
Hanny Wassef Canada	13	624 2.2×	250 2.0×	44 0.4×	120 1.1×	15 0.2×	17	876
Jason S. Troutt United States	18	1.2k 4.2×	253 2.0×	47 0.4×	232 2.1×	95 1.0×	26	1.6k
Nianping Hu Canada	11	191 0.7×	514 4.0×	123 1.1×	140 1.3×	18 0.2×	21	1.2k
Paul Lebeau Canada	17	212 0.7×	208 1.6×	40 0.4×	107 1.0×	16 0.2×	26	586
Yuichi Nakamura Japan	18	184 0.6×	393 3.1×	149 1.3×	73 0.7×	111 1.1×	62	1.0k
Long Jiang China	18	274 1.0×	318 2.5×	162 1.5×	90 0.8×	7 0.1×	69	974
Ashley Brooks United Kingdom	8	377 1.3×	370 2.9×	33 0.3×	100 0.9×	16 0.2×	12	927
D Lauri Italy	14	54 0.2×	298 2.3×	133 1.2×	101 0.9×	39 0.4×	25	733

Countries citing papers authored by Henry Pan

Since Specialization

Citations

This map shows the geographic impact of Henry Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Pan more than expected).

Fields of papers citing papers by Henry Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Pan. The network helps show where Henry Pan may publish in the future.

Co-authorship network of co-authors of Henry Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Pan. A scholar is included among the top collaborators of Henry Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Pan. Henry Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Pan, Henry, et al.. (2022). Salmonella Mississippi: An unusual cause of renal abscess in an immunocompetent patient. Urology Case Reports. 45. 102197–102197.

Shin, Paul, et al.. (2010). M1058 Alosetron is Associated With Improvements in Treatment Satisfaction and Quality of Life. Gastroenterology. 138(5). S–322. 1 indexed citations

Ameen, Vanessa Z., et al.. (2008). The Risk Management Program (Riskmap) Is Effective in Mitigating Serious Outcomes of Ischemic Colitis and Complications of Constipation with Marketed Use of Alosetron Since Reintroduction. The American Journal of Gastroenterology. 103. S468–S469. 2 indexed citations

Struthers, R. Scott, Takung Chen, Bruce Campbell, et al.. (2007). Suppression of Serum Luteinizing Hormone in Postmenopausal Women by an Orally Administered Nonpeptide Antagonist of the Gonadotropin-Releasing Hormone Receptor (NBI-42902). Obstetrical & Gynecological Survey. 62(3). 187–189. 1 indexed citations

Struthers, R. Scott, Takung Chen, Bruce Campbell, et al.. (2006). Suppression of Serum Luteinizing Hormone in Postmenopausal Women by an Orally Administered Nonpeptide Antagonist of the Gonadotropin-Releasing Hormone Receptor (NBI-42902). The Journal of Clinical Endocrinology & Metabolism. 91(10). 3903–3907. 29 indexed citations

Garland, Linda L., Barbara J. Gitlitz, Scot Ebbinghaus, et al.. (2005). Phase I Trial of Intravenous IL-4 Pseudomonas Exotoxin Protein (NBI-3001) in Patients with Advanced Solid Tumors That Express the IL-4 Receptor. Journal of Immunotherapy. 28(4). 376–381. 39 indexed citations

Weber, Friedrich, Anthony L. Asher, Richard D. Bucholz, et al.. (2003). Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma. Journal of Neuro-Oncology. 64(1-2). 125–137. 165 indexed citations

Weber, Friedrich, Anthony L. Asher, Richard D. Bucholz, et al.. (2003). Safety, Tolerability, and Tumor Response of IL4-Pseudomonas Exotoxin (NBI-3001) in Patients with Recurrent Malignant Glioma. Journal of Neuro-Oncology. 64(1). 125–137. 14 indexed citations

Triscari, Joseph, Denis O’Donnell, Miguel A. Zinny, & Henry Pan. (1995). Gastrointestinal Absorption of Pravastatin in Healthy Subjects. The Journal of Clinical Pharmacology. 35(2). 142–144. 33 indexed citations

10.

Triscari, Joseph, et al.. (1995). CHRONOKINETICS OF PRAVASTATIN ADMINISTERED IN THE PM COMPARED WITH AM DOSING. American Journal of Therapeutics. 2(4). 265–268. 6 indexed citations

11.

Mellies, Margot J., et al.. (1993). Pravastatin experience in elderly and non-elderly patients. Atherosclerosis. 101(1). 97–110. 20 indexed citations

12.

Halstenson, Charles E., et al.. (1992). Single‐Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment. The Journal of Clinical Pharmacology. 32(2). 124–132. 49 indexed citations

13.

Pan, Henry, et al.. (1990). Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia. Clinical Pharmacology & Therapeutics. 48(2). 201–207. 69 indexed citations

14.

Hunninghake, Donald B., Margot J. Mellies, Anne C. Goldberg, et al.. (1990). Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. Atherosclerosis. 85(2-3). 219–227. 75 indexed citations

15.

Pan, Henry, Arthur R. DeVault, David Wang‐Iverson, et al.. (1990). Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin. The Journal of Clinical Pharmacology. 30(12). 1128–1135. 130 indexed citations

16.

Pan, Henry, et al.. (1986). The Mackerel was in Fact a Red Herring. Drug Intelligence & Clinical Pharmacy. 20(9). 687–689. 1 indexed citations

17.

Pan, Henry, et al.. (1985). Wilson's Disease in a Patient Presenting with Skeletal Abnormalities. Orthopedics. 8(6). 742–744. 7 indexed citations

18.

Pan, Henry, et al.. (1984). Efficacy of two proprietary preparations of frusemide in patients with congestive heart failure. The Medical Journal of Australia. 140(4). 221–222. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact